Skip to main content

Portfolio Update (Correction)

Written by Customer Service on . Posted in Public Companies.

Downing FOUR VCT plc (the “Company”)
LEI: 21380035MV1VRYEXPR95
7 June 2021
Portfolio Update (Correction)

The announcement issued by the Company on 3 June 2021 at 15:47 contained an error in respect of the increase in value of the Company’s holdings in Arecor Therapeutics plc on its admission to AIM. The correct figures for the increase in value of the Company’s holdings were 0.7p per Generalist Share and 6.3p per Healthcare Share (not 0.9p and 8.0p as originally stated). This equates to increases of 1.0% and 9.0% in the NAV of the Generalist Shares and Healthcare Shares (not 1.3% and 11.4% as originally stated).

The full corrected text of the 3 June 2021 announcement is as follows:

The Directors of the Company are pleased to report that Generalist and Healthcare Share portfolio company, Arecor Therapeutics (“Arecor”), has today (3 June 2021) had its ordinary shares admitted to trading on AIM. The admission follows a successful £20.0 million placing of new shares at a price of 226 pence per ordinary share (the “placing price”).

Based on the placing price, the values of the Company’s Generalist and Healthcare Share pools’ holdings in Arecor have increased by approximately 0.7p per Generalist Share and 6.3p per Healthcare Share (based on shares in issue at 28 February 2021, being the date of the latest NAVs announced by the Company). This is equivalent to increases of 1.0% and 9.0% in the unaudited NAVs of the Generalist and Healthcare Share pools respectively, as at 28 February 2021.

Enquiries:
Grant Whitehouse
Downing LLP
Company Secretary
020 7630 4333

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.